Deborah Andrews serves as Chief Financial Officer of STAAR Surgical Company, a leading innovator in ophthalmic products, including advanced intraocular lenses for cataract surgery and refractive vision correction. Appointed to the role in September 2021, she oversees all financial operations, including strategic planning, financial reporting, investor relations, treasury management, and compliance. With more than 25 years of experience in the healthcare and medical device sectors, Andrews has a proven track record of driving financial excellence and supporting business growth in dynamic, regulated environments. Prior to joining STAAR Surgical, Andrews was CFO at Omeros Corporation, a clinical-stage biopharmaceutical company, from 2018 to 2021, where she managed capital raises, including public offerings totaling over $200 million, and navigated complex financial challenges during clinical development phases. Before that, she served as Vice President of Finance and Treasurer at Wright Medical Group from 2014 to 2018, leading global financial planning, analysis, and mergers and acquisitions during a period of international expansion and operational transformation. Her career began at Deloitte & Touche, where she advanced to Senior Manager, specializing in audits and advisory services for healthcare clients. Under Andrews' stewardship, STAAR Surgical has achieved robust revenue growth, enhanced operational efficiencies, and strengthened its balance sheet to fuel innovation and global market penetration. Her strategic leadership has been pivotal in positioning the company for long-term success amid evolving industry demands, earning her recognition as a key executive driving shareholder value.